KBC Group NV Sells 2,711 Shares of Tenet Healthcare Corporation $THC

KBC Group NV reduced its position in Tenet Healthcare Corporation (NYSE:THC) by 5.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,539 shares of the company’s stock after selling 2,711 shares during the quarter. KBC Group NV owned 0.06% of Tenet Healthcare worth $9,537,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. Wedmont Private Capital increased its holdings in Tenet Healthcare by 2.5% during the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after buying an additional 50 shares during the period. Baron Wealth Management LLC boosted its position in Tenet Healthcare by 4.8% during the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock valued at $227,000 after acquiring an additional 52 shares in the last quarter. PeakShares LLC raised its position in shares of Tenet Healthcare by 3.3% in the 1st quarter. PeakShares LLC now owns 1,693 shares of the company’s stock worth $319,000 after acquiring an additional 54 shares in the last quarter. Sagespring Wealth Partners LLC lifted its stake in shares of Tenet Healthcare by 3.6% during the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock worth $313,000 after purchasing an additional 55 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its position in Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after purchasing an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Down 0.3%

Tenet Healthcare stock opened at $195.84 on Thursday. The business’s 50-day simple moving average is $184.41 and its two-hundred day simple moving average is $197.37. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The company has a market cap of $16.87 billion, a PE ratio of 10.18, a PEG ratio of 1.63 and a beta of 1.27. Tenet Healthcare Corporation has a fifty-two week low of $146.60 and a fifty-two week high of $247.21.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the prior year, the firm earned $4.36 earnings per share. Tenet Healthcare’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 17.5 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on THC shares. Wells Fargo & Company boosted their target price on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Barclays lifted their price objective on shares of Tenet Healthcare from $238.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 8th. Morgan Stanley set a $254.00 target price on shares of Tenet Healthcare in a research report on Friday, May 1st. KeyCorp cut their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, Stephens decreased their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $244.84.

Insiders Place Their Bets

In related news, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nadja West sold 3,000 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the sale, the director directly owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.